Area of research
Nephrology · Molecular Biology
Research interest
Research interests include Parathyroid Disorders and Treatments, Fibroblast Growth Factor Research, Renal Diseases and Glomerulopathies, and Genetic Syndromes and Imprinting.
Soft tissue calcifications in chronic kidney disease—beyond the vasculature
The Pathologic Actions of Phosphate in CKD
Skeletal Muscle Injury in Chronic Kidney Disease—From Histologic Changes to Molecular Mechanisms and to Novel Therapies
FGFR4 Is Required for Concentric Growth of Cardiac Myocytes during Physiologic Cardiac Hypertrophy
Fibroblast growth factor 23, klotho and heparin
Phosphate induces inflammation and exacerbates injury from cigarette smoke in the bronchial epithelium
Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease
FGF21-FGFR4 signaling in cardiac myocytes promotes concentric cardiac hypertrophy in mouse models of diabetes
Fibroblast growth factor 23 (FGF23) induces ventricular arrhythmias and prolongs QTc interval in mice in an FGF receptor 4-dependent manner
FGF23, a novel muscle biomarker detected in the early stages of ALS
Fibroblast Growth Factor Receptor 4 Deficiency Mediates Airway Inflammation in the Adult Healthy Lung?
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease
The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia
Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis
FGF23 and inflammation—a vicious coalition in CKD
FGFR4 does not contribute to progression of chronic kidney disease
FGF23 Actions on Target Tissues—With and Without Klotho
DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport Syndrome
Fibroblast growth factor 23 and Klotho contribute to airway inflammation
Cardioprotective Effects of Paricalcitol Alone and in Combination With FGF23 Receptor Inhibition in Chronic Renal Failure: Experimental and Clinical Studies
FGF23 effects on the heart—levels, time, source, and context matter
STAT3-enhancing germline mutations contribute to tumor-extrinsic immune evasion
FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
Klotho Inhibits Interleukin-8 Secretion from Cystic Fibrosis Airway Epithelia
Fibroblast Growth Factor 23: Mineral Metabolism and Beyond
Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease
Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury
Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease
Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats
Cardiac actions of fibroblast growth factor 23